
|Videos|March 29, 2016
Disadvantages of Novel Oral Anticoagulants Compared with Vitamin K Antagonists
John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, talks about the disadvantages of novel oral anticoagulants over vitamin K antagonists.
Advertisement
John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, talks about the disadvantages of novel oral anticoagulants over vitamin K antagonists.
This video was recorded at APhA's 2016 Annual Meeting and Exposition in Baltimore, Maryland.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Accepts Furosemide Autoinjector sNDA for Treatment of Edema in Chronic Kidney Disease or Chronic Heart Failure
2
FDA Approves Pirtobrutinib for Relapsed or Refractory Chronic Lymphocytic Leukemia
3
A Closer Look at Interdisciplinary Care with Unit-Based Pharmacy
4
Examining the Safety Profiles of SG and Pembrolizumab in ASCENT-04
5



















































































































































































































